Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1215
|
339
|
0.080 |
None |
1.000 |
8 |
|
2008 |
2020 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Epilepsy, Temporal Lobe
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
354
|
33
|
0.210 |
None |
1.000 |
2 |
|
2011 |
2012 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2018 |
Drug Resistant Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
184
|
35
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2011 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.200 |
None |
1.000 |
2 |
|
1999 |
2001 |
Status Epilepticus
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
533
|
12
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2013 |
Rasmussen subacute encephalitis
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
17
|
1
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2017 |
Rasmussen Syndrome
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
18
|
3
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Anoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
287
|
|
0.310 |
None |
1.000 |
2 |
|
2008 |
2009 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Severe combined immunodeficiency due to adenosine deaminase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
24
|
15
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Aplasia Cutis Congenita
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
393
|
14
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adenosine deaminase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
17
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Combined molybdoflavoprotein enzyme deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hypoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pulmonary congestion
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
bone destruction
|
disease |
|
Disease or Syndrome
|
234
|
3
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Acinar Cell Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
65
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adenoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
49
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |